Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.


Wagner, AD, Grabsch, HI, Mauer, M et al. (12 more authors) (2019) EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group. BMC Cancer, 19. 494. ISSN 1471-2407

Slagter, AE, Jansen, EPM, van Laarhoven, HWM et al. (19 more authors) (2018) CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. BMC Cancer, 18. 877. ISSN 1471-2407

Bosch, SL, Vermeer, TA, West, NP et al. (8 more authors) (2016) Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy. Histopathology, 69 (5). pp. 839-848. ISSN 0309-0167

Feilchenfeldt, J, Varga, Z, Siano, M et al. (19 more authors) (2015) Brain metastases in gastro-oesophageal adenocarcinoma: Insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113 (5). pp. 716-721. ISSN 0007-0920

This list was generated on Sat Jan 18 20:31:12 2020 GMT.